Mal-PEG6-NHS - CAS 1137109-21-7

Mal-PEG6-NHS - CAS 1137109-21-7 Catalog number: BADC-00442

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Mal-PEG6-NHS is a widely employed biomedical reagent within drug delivery systems and bioconjugation processes. Embedding a maleimide moiety facilitates precise targeting, while supplemented with a polyethylene glycol (PEG) spacer, it accomplishes elevated solubility and biocompatibility. Resultantly, Mal-PEG6-NHS serves as a pivotal constituent enabling the formulation of therapeutic agents to combat a spectrum of illnesses encompassing cancer, cardiovascular ailments, and inflammatory disorders.

Category
ADCs Linker
Product Name
Mal-PEG6-NHS
CAS
1137109-21-7
Catalog Number
BADC-00442
Molecular Formula
C26H39N3O13
Molecular Weight
601.60
Purity
≥98%
Mal-PEG6-NHS

Ordering Information

Catalog Number Size Price Quantity
BADC-00442 -- $-- Inquiry
Description
Mal-PEG6-NHS is a widely employed biomedical reagent within drug delivery systems and bioconjugation processes. Embedding a maleimide moiety facilitates precise targeting, while supplemented with a polyethylene glycol (PEG) spacer, it accomplishes elevated solubility and biocompatibility. Resultantly, Mal-PEG6-NHS serves as a pivotal constituent enabling the formulation of therapeutic agents to combat a spectrum of illnesses encompassing cancer, cardiovascular ailments, and inflammatory disorders.
Synonyms
Maleimide-PEG6-succinimidyl ester; 4,7,10,13,16,19-Hexaoxa-22-azapentacosanoic acid, 25-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-23-oxo-, 2,5-dioxo-1-pyrrolidinyl ester
IUPAC Name
(2,5-dioxopyrrolidin-1-yl) 3-[2-[2-[2-[2-[2-[2-[3-(2,5-dioxopyrrol-1-yl)propanoylamino]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]propanoate
Canonical SMILES
C1CC(=O)N(C1=O)OC(=O)CCOCCOCCOCCOCCOCCOCCNC(=O)CCN2C(=O)C=CC2=O
InChI
InChI=1S/C26H39N3O13/c30-21(5-8-28-22(31)1-2-23(28)32)27-7-10-37-12-14-39-16-18-41-20-19-40-17-15-38-13-11-36-9-6-26(35)42-29-24(33)3-4-25(29)34/h1-2H,3-20H2,(H,27,30)
InChIKey
AVCPTIUOZBWCKE-UHFFFAOYSA-N
Appearance
Soild powder
Shipping
Room temperature, or blue ice upon request.
Storage
Pure form, -20°C, 3 years; In solvent, -80°C, 6 months; -20°C, 1 month

Mal-PEG6-NHS is a highly versatile reagent commonly used in bioconjugation for drug delivery, diagnostics, and therapeutic applications. This compound features a maleimide (Mal) group that enables specific conjugation to thiol-containing biomolecules, such as proteins, peptides, and antibodies. The PEG6 (polyethylene glycol) spacer provides excellent solubility and improves the pharmacokinetic properties of the conjugate by increasing its stability in biological fluids. The NHS (N-hydroxysuccinimide) ester is a reactive group that enables efficient coupling to amine-containing molecules, making Mal-PEG6-NHS a key component in the development of targeted therapies and diagnostic tools.

One of the primary applications of Mal-PEG6-NHS is in the creation of antibody-drug conjugates (ADCs) for cancer therapy. The maleimide group allows the reagent to easily attach to monoclonal antibodies that specifically recognize cancer cell antigens. The PEG6 spacer improves the solubility and circulation time of the conjugate, helping to avoid premature clearance from the bloodstream. The NHS ester facilitates the conjugation of cytotoxic drugs or small molecules to the antibody via amine groups. This targeted approach ensures that the drug is delivered selectively to cancer cells, significantly reducing systemic toxicity while enhancing the therapeutic effect of the drug.

Mal-PEG6-NHS is also valuable for the development of peptide-based conjugates. By conjugating peptides that target specific biomarkers to therapeutic agents or imaging probes, Mal-PEG6-NHS enables the selective delivery of drugs to disease sites, such as tumors, or allows for high-precision molecular imaging. The PEG6 spacer provides sufficient flexibility and stability, ensuring that the conjugate maintains its bioactivity. The NHS ester is reactive toward amine-containing drugs or imaging agents, allowing for efficient conjugation and controlled release at the target site. This approach is particularly useful for precision medicine, where therapies can be tailored to the specific needs of individual patients.

In addition to its role in drug delivery, Mal-PEG6-NHS is widely used in diagnostic applications, such as biomarker detection and imaging. By conjugating diagnostic antibodies or peptides to imaging agents, Mal-PEG6-NHS can be employed in techniques like positron emission tomography (PET) or magnetic resonance imaging (MRI). The PEG6 spacer ensures the stability and solubility of the conjugate in the bloodstream, improving its distribution to target tissues. The NHS ester enables efficient coupling to biomolecules, allowing for precise targeting of disease sites like tumors, facilitating early detection and accurate monitoring of disease progression or treatment response.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Historical Records: Mal-PEG6-NHS
Why Choose BOC Sciences?

Customer Support

Providing excellent 24/7 customer service and support

Project Management

Offering 100% high-quality services at all stages

Quality Assurance

Ensuring the quality and reliability of products or services

Global Delivery

Ensuring timely delivery of products worldwide

Questions & Comments
Verification code
Send Inquiry
Verification code
Resources & Supports
Inquiry Basket